Cardioplegia cannulae increases the myocardial protection during a
cardiac surgery. Research studies have indicated that, in case of
patients undergoing cardiac arrest, especially on-pump cardiac
surgeries, combined use of retrograde and ante-grade cardioplegia is
the best treatment approach for increasing myocardial protection.
Cardioplegia cannulae are used in various types of surgeries such as
coronary sinus perfusion and minimally invasive aortic root
surgeries. In these procedures, a standard cannula is difficult to
insert, as it involves a risk of myocardial abrasion. Introduction of
technologically advanced products such as cannula with phospholipid
coating enhancing biocompatibility, are factors driving the growth of
the market in 2016.
Adequate reimbursement policies for cardiovascular surgeries and
related products, rising preference for minimally invasive
techniques, increasing per capita health care expenditure in emerging
countries, and improving healthcare infrastructure are some of the
factors likely to drive the global cardioplegia cannulae market
during the forecast period. However, high cost of equipment and
requirement for skilled physicians to perform surgeries are some of
the factors restraining the global cardioplegia cannulae market.
Several emerging players are coming up with cost-effective products
with innovative technologies. This factor is likely to augment the
global cardioplegia cannulae market during the forecast period.
The global cardioplegia cannulae market can be segmented based on
product type, usage type, type of material used, end-user, and
region. Based on product type, the market has been bifurcated into
ante-grade cannulae and retrograde cannulae. The ante-grade
cardioplegia refers to delivery of solutions via coronary arteries,
whereas the retrograde cardioplegia refers to delivery of solutions
through coronary veins. The retrograde cardioplegia cannulae segment
has been further divided into self-inflating balloons and manually
inflating balloons. These balloons are either smooth or textured. In
terms of usage type, the global cardioplegia cannulae market has been
classified into re-usable cardioplegia cannulae and
single-use/disposable cardioplegia cannulae. Based on type of
material used, the market has been categorized into polyurethane,
silicone, polyvinyl chloride (PVC), biocompatible material, and
others. Based on end-user, the market has been divided into
hospitals, cardiac clinics, and ambulatory surgical centers.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33854
Based on geography, the global cardioplegia cannulae market has been
segmented into five regions: North America, Europe, Asia Pacific,
Latin America, and Middle East & Africa. North America is likely
to dominate the global cardioplegia cannulae market, in terms of
revenue, during the forecast period. This is attributable to high
average selling price of the product, high adoption of advanced
minimally invasive techniques by end-users, and rise in the incidence
of cardiovascular abnormalities caused by sedentary lifestyle.
However, the market in Asia Pacific is projected to expand at a
significant CAGR during the forecast period, due to the large number
of patients with cardiovascular diseases, increase in the market
penetration by local manufacturers, and low entry barriers for
established market players in the region to enhance their
geographical presence.
Superior technological innovations such as suture flanges and luer
locking needles are likely to increase the rate of adoption of
cardioplegia cannulae during the forecast period. Rising number of
mergers and collaborations by major market players to penetrate this
relatively untapped market with high growth potential is a growing
trend. Development of skilled surgeons and establishment of proper
infrastructure in developing countries are likely to offer growth
opportunities to the global cardioplegia cannulae market during the
forecast period.
Key players operating in the global cardioplegia cannulae market are
Edwards Lifesciences Corporation, Medtronic, (Sorin Group) LivaNova
PLC, (Terumo Cardiovascular Systems Corporation) TERUMO CORPORATION,
ANDOCOR N.V., Braile Biomédica, Surge Cardiovascular, (MAQUET
Holding B.V. & Co. KG.) Getinge Group, and Vitalcor, Inc.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=33854<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment